Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This track will explore the latest research and clinical practices in managing Type 1 and Type 2 diabetes. Emphasis will be placed on innovative treatment strategies and patient-centered care approaches.
This session will focus on the complexities of gestational diabetes, including its diagnosis, management, and long-term implications for both mother and child. Discussions will highlight recent advancements in screening and intervention strategies.
This track will delve into the pathophysiology of autoimmune diabetes mellitus and its subtypes. Participants will discuss emerging therapeutic interventions and their clinical implications.
Focusing on diabetes in children, this session will address the specific challenges faced in diagnosis and management. Innovative approaches and technologies aimed at improving outcomes in pediatric populations will be highlighted.
This track will examine the epidemiology and risk factors associated with prediabetes. Strategies for early detection and intervention to prevent progression to diabetes will be discussed.
This session will focus on the genetic underpinnings of monogenic forms of diabetes and neonatal diabetes. Participants will explore diagnostic challenges and management strategies for these rare conditions.
This track will provide an in-depth analysis of the complications associated with diabetes, including cardiovascular, renal, and neuropathic issues. Recent research findings and management strategies will be discussed.
This session will highlight cutting-edge technologies that are transforming diabetes care, including continuous glucose monitoring and insulin delivery systems. Discussions will focus on the integration of these technologies into clinical practice.
This track will explore the latest advancements in drug discovery and the identification of biomarkers for diabetes treatment. Participants will discuss the implications of these developments for clinical practice.
This session will focus on the application of computational methods in diabetes research, including data analysis and modeling. Participants will explore how these approaches can enhance understanding and treatment of diabetes.
This track will examine the regulatory frameworks and economic considerations impacting diabetes research and treatment. Discussions will focus on the implications for policy and practice in the healthcare system.